CCND1 and laryngeal carcinoma: Recently, the team of Xi Tan has reported that ECD inhibits the growth of laryngeal carcinoma via the STAT3/Cyclin D1 pathway and it was the first study on the mechanism of ECD in the treatment of tumors (Tan et al., 2020).